Novel Insight into Inflammatory Pathways in Acute Pulmonary Embolism in Humans
Archivum Immunologiae et Therapiae Experimentalis · 2024
DOI: 10.2478/aite-2024-0021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2024. Verfasst von Anna M Imiela und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Cardiology, Center for Venous Thromboembolism Disease, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Pulmonary Embolism, Inflammation, Biomarkers, Cytokines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Accumulating data have shown a pathophysiological association between inflammatory pathways and thrombosis. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and acute pulmonary embolism (APE), is a significant health burden. It involves not only hemodynamic disturbances due to the emboli occluding the pulmonary arteries, but also platelet activation, endothelial dysfunction, and “firing up” of the inflammatory cascade. In humans, the systemic inflammatory state can also be evaluated using plasma levels of C-reactive protein (CRP) and interleukin (IL)-6, which correlate with venous obstruction, thrombus extension, and clinical VTE complications such as postthrombotic syndrome, recurrent thromboembolism, worse quality of life, and functional impairment. The exaggerated inflammatory state during postthrombotic syndrome aligns with severe alterations in endothelial function, such as activation of intercellular adhesion molecule (ICAM)-1 and E-selectin, as well as vascular proteolysis and fibrinolysis. Moreover, a hypercoagulable state, indicated by higher levels of von Willebrand factor (vWF) and factor VIII, is closely associated with the inflammatory response. We aimed to describe the role of basic inflammatory markers in daily clinical practice as well as the most important cytokines (IL-1β, IL-6, IL-8, tumor necrosis factor-a [TNF-α], growth differentiation factor-15 [GDF-15]). These markers could provide valuable insight into the interplay between thrombosis and inflammation, helping inform better management and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Cardiology, Center for Venous Thromboembolism Disease, Medical University of Warsaw, Warsaw, Poland.
- Department of Internal and Agricultural Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
- Center for Medical Genomics OMICRON, Jagiellonian University Medical College.
Zitieren
APA
Imiela, A. M., Mikołajczyk, T. P., & Pruszczyk, P. (2024). Novel Insight into Inflammatory Pathways in Acute Pulmonary Embolism in Humans. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2024-0021
Vancouver
Imiela AM, Mikołajczyk TP, Pruszczyk P. Novel Insight into Inflammatory Pathways in Acute Pulmonary Embolism in Humans. Archivum Immunologiae et Therapiae Experimentalis. 2024. doi:10.2478/aite-2024-0021
BibTeX
@article{Imiela2024,
author = {Imiela, Anna M and Mikołajczyk, Tomasz P and Pruszczyk, Piotr},
title = {Novel Insight into Inflammatory Pathways in Acute Pulmonary Embolism in Humans},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2024},
doi = {10.2478/aite-2024-0021}
}
EUVIMED